4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid

C51H73N3O5 — CID 129126910

IUPAC4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
SMILESCC(C)(CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4[C@H]5C(C6(C)CC6)CC[C@]5(C(=O)N5CCC(c6ncc(-c7ccccc7)[nH]6)CC5)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C(=O)O
InChIInChI=1S/C51H73N3O5/c1-45(2,44(57)58)30-40(55)59-39-18-21-48(6)37(46(39,3)4)17-22-50(8)38(48)15-14-35-41-34(47(5)24-25-47)16-23-51(41,27-26-49(35,50)7)43(56)54-28-19-33(20-29-54)42-52-31-36(53-42)32-12-10-9-11-13-32/h9-13,31,33-35,37-39,41H,14-30H2,1-8H3,(H,52,53)(H,57,58)/t34?,35-,37+,38-,39+,41-,48+,49-,50-,51+/m1/s1
InChIKeyFZGHTYAWHRFWFJ-RHDIBAOUSA-N
MW808.16 g/mol
LogP11.08
Rot. Bonds8

About 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid

4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid (PubChem CID 129126910) has the molecular formula C51H73N3O5 and a molecular weight of 808.16 g/mol. Its IUPAC name is 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid.

Molecular Properties

Compound Name4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
PubChem CID129126910
Molecular FormulaC51H73N3O5
Molecular Weight808.16 g/mol
Exact Mass807.56
IUPAC Name4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
SMILESCC(C)(CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4[C@H]5C(C6(C)CC6)CC[C@]5(C(=O)N5CCC(c6ncc(-c7ccccc7)[nH]6)CC5)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C(=O)O
InChIInChI=1S/C51H73N3O5/c1-45(2,44(57)58)30-40(55)59-39-18-21-48(6)37(46(39,3)4)17-22-50(8)38(48)15-14-35-41-34(47(5)24-25-47)16-23-51(41,27-26-49(35,50)7)43(56)54-28-19-33(20-29-54)42-52-31-36(53-42)32-12-10-9-11-13-32/h9-13,31,33-35,37-39,41H,14-30H2,1-8H3,(H,52,53)(H,57,58)/t34?,35-,37+,38-,39+,41-,48+,49-,50-,51+/m1/s1
InChIKeyFZGHTYAWHRFWFJ-RHDIBAOUSA-N
XLogP11.08
TPSA112.59 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds8
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500808.16
LogP ≤ 511.08
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The IUPAC name of 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid (CID 129126910) is 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid.
What is the SMILES notation for 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The canonical SMILES for 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid is CC(C)(CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4[C@H]5C(C6(C)CC6)CC[C@]5(C(=O)N5CCC(c6ncc(-c7ccccc7)[nH]6)CC5)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C(=O)O.
What is the InChIKey of 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The InChIKey is FZGHTYAWHRFWFJ-RHDIBAOUSA-N. The full InChI is InChI=1S/C51H73N3O5/c1-45(2,44(57)58)30-40(55)59-39-18-21-48(6)37(46(39,3)4)17-22-50(8)38(48)15-14-35-41-34(47(5)24-25-47)16-23-51(41,27-26-49(35,50)7)43(56)54-28-19-33(20-29-54)42-52-31-36(53-42)32-12-10-9-11-13-32/h9-13,31,33-35,37-39,41H,14-30H2,1-8H3,(H,52,53)(H,57,58)/t34?,35-,37+,38-,39+,41-,48+,49-,50-,51+/m1/s1.
What are the key properties of 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid has a molecular weight of 808.16 g/mol, XLogP of 11.08, 8 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-[4-(5-phenyl-1H-imidazol-2-yl)piperidine-1-carbonyl]-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid is sourced from PubChem (CID 129126910), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).